134 related articles for article (PubMed ID: 37944329)
1. Disparities in brachytherapy utilization in cervical cancer in the United States: A comprehensive literature review.
Kumar R; Sherwani Z; Lopez M; Vergalasova I; Zhang X; Eckroate B; Hollingsworth J; Girda E; Hathout L
Gynecol Oncol; 2023 Dec; 179():79-84. PubMed ID: 37944329
[TBL] [Abstract][Full Text] [Related]
2. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements.
Gill BS; Lin JF; Krivak TC; Sukumvanich P; Laskey RA; Ross MS; Lesnock JL; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1083-90. PubMed ID: 25216857
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities.
Boyce-Fappiano D; Nguyen KA; Gjyshi O; Manzar G; Abana CO; Klopp AH; Kamrava M; Orio PF; Thaker NG; Mourtada F; Venkat P; Chang AJ
JCO Oncol Pract; 2021 Dec; 17(12):e1958-e1967. PubMed ID: 34550749
[TBL] [Abstract][Full Text] [Related]
4. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
5. Why brachytherapy boost is the treatment of choice for most women with locally advanced cervical carcinoma?
Al Feghali KA; Elshaikh MA
Brachytherapy; 2016; 15(2):191-9. PubMed ID: 26810408
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic Body Radiation Therapy, Intensity-Modulated Radiation Therapy, and Brachytherapy Boost Modalities in Invasive Cervical Cancer: A Study of the National Cancer Data Base.
OʼDonnell B; Shiao JC; Pezzi TA; Waheed N; Sharma S; Bonnen MD; Ludwig MS
Int J Gynecol Cancer; 2018 Mar; 28(3):563-574. PubMed ID: 29324547
[TBL] [Abstract][Full Text] [Related]
7. Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.
Alimena S; Yang DD; Melamed A; Mahal BA; Worley MJ; Feldman S; Elias KM; Orio PF; Lee LJ; King M
Gynecol Oncol; 2019 Sep; 154(3):595-601. PubMed ID: 31292103
[TBL] [Abstract][Full Text] [Related]
8. Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer.
Lin AJ; Kidd E; Dehdashti F; Siegel BA; Mutic S; Thaker PH; Massad LS; Powell MA; Mutch DG; Markovina S; Schwarz J; Grigsby PW
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1088-1097. PubMed ID: 30445171
[TBL] [Abstract][Full Text] [Related]
9. Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy.
Lazzari R; Riva G; Augugliaro M; Vavassori A; Dicuonzo S; Cattani F; Comi S; Colombo N; Jereczek-Fossa BA
Int J Gynecol Cancer; 2020 May; 30(5):607-612. PubMed ID: 32188626
[TBL] [Abstract][Full Text] [Related]
10. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Petersen JB; Nielsen SK; Lindegaard JC; Tanderup K
Acta Oncol; 2008; 47(7):1337-43. PubMed ID: 18663651
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional dose accumulation in pseudo-split-field IMRT and brachytherapy for locally advanced cervical cancer.
Sun B; Yang D; Esthappan J; Garcia-Ramirez J; Price S; Mutic S; Schwarz JK; Grigsby PW; Tanderup K
Brachytherapy; 2015; 14(4):481-9. PubMed ID: 25958039
[TBL] [Abstract][Full Text] [Related]
12. Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS).
Holschneider CH; Petereit DG; Chu C; Hsu IC; Ioffe YJ; Klopp AH; Pothuri B; Chen LM; Yashar C
Gynecol Oncol; 2019 Mar; 152(3):540-547. PubMed ID: 30665615
[TBL] [Abstract][Full Text] [Related]
13. Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California.
Mayadev J; Klapheke A; Yashar C; Hsu IC; Kamrava M; Mundt AJ; Mell LK; Einck J; Benedict S; Valicenti R; Cress R
Gynecol Oncol; 2018 Jul; 150(1):73-78. PubMed ID: 29709291
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
[No Abstract] [Full Text] [Related]
15. A dosimetric comparison of Volumetric Modulated Arc Therapy (VMAT) and High Dose Rate (HDR) brachytherapy in localized cervical cancer radiotherapy.
Wali L; Helal A; Darwesh R; Attar M
J Xray Sci Technol; 2019; 27(3):473-483. PubMed ID: 30958322
[TBL] [Abstract][Full Text] [Related]
16. Time-driven activity-based cost comparison of prostate cancer brachytherapy and intensity-modulated radiation therapy.
Dutta SW; Bauer-Nilsen K; Sanders JC; Trifiletti DM; Libby B; Lash DH; Lain M; Christodoulou D; Hodge C; Showalter TN
Brachytherapy; 2018; 17(3):556-563. PubMed ID: 29519605
[TBL] [Abstract][Full Text] [Related]
17. Advances in Radiation Oncology for the Treatment of Cervical Cancer.
Faye MD; Alfieri J
Curr Oncol; 2022 Feb; 29(2):928-944. PubMed ID: 35200578
[TBL] [Abstract][Full Text] [Related]
18. Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS).
Holschneider CH; Petereit DG; Chu C; Hsu IC; Ioffe YJ; Klopp AH; Pothuri B; Chen LM; Yashar C
Brachytherapy; 2019; 18(2):123-132. PubMed ID: 30665713
[TBL] [Abstract][Full Text] [Related]
19. Better late than never: Brachytherapy is more important than timing in treatment of locally advanced cervical cancer.
Korenaga TK; Yoshida EJ; Pierson W; Chang J; Ziogas A; Swanson ML; Chapman JS; Sinha S; Chen LM
Gynecol Oncol; 2022 Feb; 164(2):348-356. PubMed ID: 34865860
[TBL] [Abstract][Full Text] [Related]
20. American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer.
Mayadev J; Viswanathan A; Liu Y; Li CS; Albuquerque K; Damato AL; Beriwal S; Erickson B
Brachytherapy; 2017; 16(1):22-43. PubMed ID: 28109631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
